HDAC6调控病毒在细胞内降解的分子机制

基本信息
批准号:31900560
项目类别:青年科学基金项目
资助金额:24.00
负责人:范存先
学科分类:
依托单位:山东师范大学
批准年份:2019
结题年份:2022
起止时间:2020-01-01 - 2022-12-31
项目状态: 已结题
项目参与者:
关键词:
蛋白翻译后修饰(protein posttranslational modification)蛋白相互作用(protein interaction)信号通路(signaling pathway)
结项摘要

Antibody-dependent intracellular neutralization (ADIN) resist viral pathogen infection as the last line of defense. The tripartite motif protein 21 (TRIM21) has been identified as a cytosolic antibody receptor, which plays critical role in ADIN. TRIM21 acts as the intracellular antibody Fc receptor to target the internalized virus-antibody complexes to the proteasome for degradation before virus has time to replicate. The regulation of TRIM21 function by post-translational modifications (PTMs) needs to be further illustrated, except for ubiquitination. In our previous study of the substrate diversity of histone deacetylase 6 (HDAC6), we found that TRIM21 was included in the list of acetylated proteins. In this study, we will dissect deeply the molecular mechanism of how HDAC6 catalyze the deacetylation of TRIM21, also will explain the functional effects regulated by TRIM21 deacetylation, further will perfect ADIN signaling pathway mediated by TRIM21. If we finally achieve the end of our research, it is expected to know more about the mechanism of ADIN mediated by TRIM21, which has important theoretical and academic value.

抗体依赖的细胞内中和效应作为机体最后一道防线,抵抗病毒感染。The tripartite motif protein 21 (TRIM21)作为胞浆内Fc受体,在其中起着关键作用。TRIM21可以识别胞浆内病毒-抗体复合物并将其靶定到蛋白酶体进行降解,致使病毒不能在细胞内发生复制。除泛素化修饰外,蛋白其他翻译后修饰如何调控TRIM21功能有待拓展和深入。前期研究发现,TRIM21作为乙酰化修饰蛋白出现在HDAC6底物多样性列表中。在该项目中,我们将深度分析HDAC6催化TRIM21发生去乙酰化修饰的分子作用机制,深度阐释TRIM21去乙酰化修饰对其功能的影响,进一步完善TRIM21介导的细胞内抗体依赖的中和效应的信号通路。预期研究结果的取得,将加深对TRIM21介导抗体依赖的细胞内中和效应作用机制的理解,提高对抗体依赖的细胞内中和效应作用机制认知,具有重要的理论和学术价值。

项目摘要

The tripartite motif protein 21 (TRIM21)可以识别胞浆内病毒-抗体复合物并将其靶定到蛋白酶体进行降解,致使病毒不能在细胞内发生复制。但是调控TRIM21活性的分子机制还不清楚。我们研究发现,HDAC6可以调控TRIM21发生去乙酰化,而且TRIM21通过PRYSPRY 结构域与HDAC6发生相互作用。进一步研究发现,HDAC6催化TRIM21在其385位赖氨酸和387位赖氨酸发生去乙酰化,进而引发TRIM21发生同源二聚化。抑制HDAC6活性会使TRIM21乙酰化水平增加,而TRIM21高度乙酰化会抑制TRIM21发生同源二聚化和泛素化修饰,进而抑制其结合病毒抗体复合物的能力,从而减少病毒抗体复合物通过泛素蛋白媒体通路降解,进而抑制了细胞内抗体依赖的中和效应,最终导致病毒在细胞内累积。而TRIM21乙酰化缺失的突变体K385/387R,会恢复由HDAC6缺失引发的抗体依赖的细胞内中和效应能力。该项目证明了HDAC6可以调控TRIM21介导的细胞内固有免疫反应。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators

Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators

DOI:10.1016/j.apsb.2020.09.010
发表时间:2021
3

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021
4

基于分形维数和支持向量机的串联电弧故障诊断方法

基于分形维数和支持向量机的串联电弧故障诊断方法

DOI:
发表时间:2016
5

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated With Fibrosis Involving Different Systems of the Human Body

DOI:10.3389
发表时间:2021

范存先的其他基金

相似国自然基金

1

调控细胞内Tau蛋白降解的活性分子研究

批准号:21472109
批准年份:2014
负责人:李艳梅
学科分类:B0706
资助金额:85.00
项目类别:面上项目
2

猪流行性腹泻病毒调控细胞内质网压力的分子机制研究

批准号:31602066
批准年份:2016
负责人:周晗
学科分类:C1802
资助金额:20.00
项目类别:青年科学基金项目
3

泛素化降解IFI16的分子机制及其在宿主抗病毒免疫中的调控作用

批准号:31800760
批准年份:2018
负责人:李大培
学科分类:C0806
资助金额:26.00
项目类别:青年科学基金项目
4

茉莉酸调控拟南芥PIN2蛋白细胞内循环与降解的分子机制研究

批准号:31170260
批准年份:2011
负责人:孙加强
学科分类:C0207
资助金额:55.00
项目类别:面上项目